Neurochemical mechanisms that enable breathing memory—a form of neuroplasticity (the ability of the nervous system to change its activity in response to injuries) known as phrenic long-term facilitation—are very dependent ...
Oct 2, 2023
0
14
Patients in some of the most deprived areas of England, where respiratory conditions including chronic lung disease (COPD) and asthma are most prevalent, have limited or no access to vital diagnostic tests to confirm their ...
Sep 27, 2023
0
1
National medicine regulator, the Food and Drug Administration (FDA), recently approved the world's first vaccines to prevent RSV, or respiratory syncytial virus, for infants and elderly adults.
Sep 14, 2023
0
12
Among hospitalized children with acute respiratory distress syndrome (ARDS) who survive to discharge, the presence or development of a chronic medical condition, tracheostomy placement during the admission, and hospitalization ...
Sep 14, 2023
0
24
Respiratory syncytial virus (RSV) is a common viral infection that affects people of all ages, with infants and older adults being particularly vulnerable to severe complications.
Sep 7, 2023
0
1
Women exposed to air pollution give birth to smaller babies, according to research that will be presented at the European Respiratory Society International Congress in Milan, Italy. The research also shows that women living ...
Sep 7, 2023
0
40
A new COVID variant is circulating. Flu season is about to begin. Respiratory syncytial virus (known as RSV) is becoming a greater cause of hospitalizations.
Sep 6, 2023
1
24
Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network ...
Aug 15, 2023
0
34
Based on decades of work to uncover the underlying mechanisms of asthma and other respiratory conditions, researchers at McMaster University and St. Joseph's Healthcare Hamilton have produced a simple, rapid test that can ...
Aug 1, 2023
0
55
Parents in the U.S. can breathe a sigh of relief: The FDA has approved a new drug that can protect infants and toddlers from RSV (respiratory syncytial virus) throughout the virus season.
Jul 28, 2023
0
1
